{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-238127","form_type":"8-K","ticker":"VBIO","cik":"0001787740","company_name":"Valion Bio, Inc.","filed_at":"2023-09-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.247545+00:00","generated_at":"2026-06-10T12:17:12.651232+00:00","sec_items":["3.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Tivic Health regains Nasdaq compliance after reverse split; delisting averted","bullets":["Nasdaq notified Tivic on Sept 15, 2023 that bid price deficiency is cured.","Company effected 1-for-100 reverse stock split on Aug 21, 2023 to cure deficiency.","Nasdaq cancelled the hearing and reversed its delisting determination.","Common stock continues trading on Nasdaq Capital Market under TIVC.","No financial impact disclosed beyond compliance status."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-238127","json":"https://secwatch.observer/filing/0001193125-23-238127.json","markdown":"https://secwatch.observer/filing/0001193125-23-238127.md","text":"https://secwatch.observer/filing/0001193125-23-238127.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787740/000119312523238127/0001193125-23-238127-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787740/000119312523238127/d556941d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T12:17:12.651232+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"47afcd3e9d860088fea9b2c2d9150b7eba66e1f4","claim":"Valion Bio, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"September 15, 2023, Nasdaq notified the Company that the Company’s bid price deficiency has been cured and that the Company is in compliance with all applicable listing standards. As a result, Nasdaq has cancelled the Hearing, reversed its delisting determination and confirmed that the Company’s common stock will continue to be listed and traded on the Nasdaq Capital Market under the symbol “TIVC.”","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787740/000119312523238127/0001193125-23-238127-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"compliance regained"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}